FIELD: medicine.
SUBSTANCE: invention represents a diagnostic technique for type II diabetes mellitus involving a biochemical blood analysis, differing by the fact that erythrocyte Cu,Zn-superoxide dismutase is determined in the patients with measured glycaemia; if the determined value is less than 1402 units/gram of haemoglobin, the presence of type II diabetes mellitus is stated.
EFFECT: more effective and accurate diagnosing of diabetes mellitus.
2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING THE EFFECTIVENESS OF A DRUG THERAPY OF ISCHEMIC HEART DISEASE BY PARAMETERS OF A CARBONYL-DEPENDENT MODIFICATION OF ERYTHROCYTE SUPEROXIDE DISMUTASE | 2020 |
|
RU2728784C1 |
| METHOD FOR ASSESSING LONG-TERM HYPERGLYCEMIA | 2013 |
|
RU2538715C1 |
| METHOD FOR EARLY PREDICTION OF THE RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 1 DIABETES MELLITUS | 2022 |
|
RU2793531C1 |
| METHOD OF DIAGNOSIS OF DIABETES DECOMPENSATION | 0 |
|
SU1772747A1 |
| METHOD FOR DIAGNOSTICS OF DIABETES MELLITUS BY LEVEL OF METHYLGLYOXAL-MODIFIED LOW-DENSITY LIPOPROTEIDS WITH APPLICATION OF MONOCLONAL ANTIBODIES | 2015 |
|
RU2612092C1 |
| METHOD FOR PREDICTING MACROANGIOPATHIES OF THE LOWER EXTREMITIES IN PATIENTS WITH TYPE 2 DIABETES | 2017 |
|
RU2662102C1 |
| MEDICATION AND METHOD OF COMPLEX THERAPY OF PATIENTS WITH DIABETES MELLITUS | 2012 |
|
RU2548731C2 |
| METHOD OF EARLY PREDICTION OF RISK OF DEVELOPMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2812643C2 |
| AGENT FOR CORRECTION OF METABOLIC SYNDROME AND METHOD OF TREATMENT OF VASCULAR COMPLICATIONS INDUCED BY CARBOHYDRATE METABOLISM IMPAIRMENT | 2001 |
|
RU2185826C1 |
| METHOD OF PREDICTING DIABETIC RETINOPATHY | 2009 |
|
RU2395227C1 |
